Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Angela F. Bazzell"'
Publikováno v:
Journal of Clinical Oncology. 40:60-60
60 Background: Advanced Practice Providers (APPs) represent a growing and increasingly important component of the oncology workforce. However, APP roles in clinical research are not clearly understood, and certain policies may limit participation. Fo
Publikováno v:
Journal of the Advanced Practitioner in Oncology
The management of head and neck cancers (HNC) and esophageal cancer (EC) is complex and often involves multiple modalities of treatment, including chemotherapy, radiation therapy, and surgery. The side effects associated with these therapies and dise
Publikováno v:
Journal of the Advanced Practitioner in Oncology
CASE STUDY A 48-year-old gentleman with metastatic melanoma currently receiving the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) inhibitor, ipilimumab (Yervoy), and the programmed cell death protein 1 (PD-1) inhibitor, nivolumab (Opdivo), ret
Publikováno v:
The Journal for Nurse Practitioners. 14:238-244
Advances in early detection and treatment of cancer have resulted in a growing population of cancer survivors across the United States. Cancer survivors may be at increased risk for the development of a second primary malignancy as a result of enviro
Comparing Outcomes of Genetic Counseling Options in Breast and Ovarian Cancer: An Integrative Review
Publikováno v:
Oncology Nursing Forum. 45:96-105
Problem identification Genetic counseling is vital in helping people at high risk for hereditary breast and ovarian cancer (HBOC) make informed decisions to undergo BRCA testing. Many people, particularly those in rural locations, lack access to thes
Autor:
Joyce E. Dains, Angela F. Bazzell
Publikováno v:
The Journal for Nurse Practitioners. 13:e375-e382
Increases in the number of nurse practitioners (NPs) completing their educational programs create a challenge for universities as well as health care organizations. More clinical preceptors are needed to support students and new professionals transit
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Allogeneic hematopoietic stem cell transplant (HSCT) remains the mainstay in treating many hematologic malignancies. T-cell–depleted grafts designed to reduce graft-vs.-host disease (GVHD) may be complicated by severe viral infections that increase
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 10
Allogeneic hematopoietic stem cell transplant (HSCT) remains the mainstay in treating many hematologic malignancies. T-cell-depleted grafts designed to reduce graft-vs.-host disease (GVHD) may be complicated by severe viral infections that increase m
Autor:
Judy Devlin, Christine Hong, Edie Brucker, Sadaf Charania, Kavitha Nair, Shayna Simon, John W. Sweetenham, Angela F. Bazzell
Publikováno v:
Journal of Clinical Oncology. 39:e13517-e13517
e13517 Background: Emergency Department (ED) utilization by oncology patients accounts for more than 4.5 million visits in the United States annually, leading to hospitalization four times the rate of the general population.1,2 Many ED visits are the
Autor:
John W. Sweetenham, Christine Hong, Kavitha Nair, Sadaf Charania, Angela F. Bazzell, Judy Devlin, Edie Brucker, Shayna Simon
Publikováno v:
Journal of Clinical Oncology. 39:e18676-e18676
e18676 Background: Oncology patients frequently experience acute physical symptoms related to cancer and its treatment. Management of symptoms is best accomplished using evidence-based clinical care. When implementing an advanced practice provider (A